TRTME: Improving Outpatient Initiation of Medication for Opioid Use Disorder Following Hospitalization
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorT. John Winhusen, PhD
About this trial
The primary objective of this study is to evaluate the ability of TRTME to increase initiation of MOUD outpatient treatment and MOUD knowledge in hospitalized patients with OUD deemed to be good candidates for MOUD by the UCMC Addiction Consult Team (ACT). The secondary objective is to evaluate the ability of TRTME to decrease stigma and increase drug self-efficacy.
Eligibility criteria
Qualifiers
18 years of age or older;
A good candidate for methadone or buprenorphine treatment according to a member of the UCMC Addiction Consult Team
Disqualifiers
Have a current planned discharge to a nursing facility
be currently in jail, prison, or any inpatient overnight facility as required by court of law or have pending legal action with high probability of incarceration or court-mandated inpatient treatment
Unable to demonstrate adequate understanding of study procedures during the consent process
Trial design
Treatments tested in this trial
- TRTME
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
T. John Winhusen, PhD
Lead sponsor
University of Cincinnati
Sponsor institution
Source ClinicalTrials.gov